ATS unveils high-speed ampoule inspection system
Canada's ATS Automation Tooling Systems has launched a fully-automated inspection system for plastic containers used as primary packaging for aseptically filled pharmaceutical products.
Archives for May 10, 2005
Protein carrier makes oral drugs out of injectables
Researchers in the US have developed a way to make large, protein-based drugs suitable for oral rather than injectable delivery by fusing them with a carrier molecule, reports Phil Taylor.
UK firms link up on separation technology
Peakdale Molecular and Dynamic Extractions are to collaborate on the development of a new separation technology with applications in drug discovery, development and manufacture.
Mederex initiates ulcerative colitis phase I trial
Medarex has announced the initiation of a phase I clinical trial of its human monoclonal antibody for the treatment of ulcerative colitis after the FDA granted the company an Investigational New Drug (IND) application.
Legal documents fly to and from Rhodia
French chemicals company Rhodia, already facing two separate investigations for alleged accounting irregularities and insider trading, has become embroiled in further legal fights just as it starts to lift itself out of financial difficulties.
Vertex reports potency for hep C treatment
Vertex Pharmaceuticals have announced the latest results that indicate the investigational oral hepatitis C virus (HCV) protease inhibitor VX-950 was well tolerated and demonstrated potent antiviral activity in a Phase Ib clinical trial.
Therapeutic antibodies realise commercial potential
According to a new report the therapeutic antibody market is expected to treble in size by 2010 as significant leaps forward coupled with safer and more effective humanised and fully human antibodies are pouring onto the market fulfilling their...
The sudden departure of Susan Vogt from Millipore – People on the move
In-PharmaTechnologist.com presents a round up of personnel news in the pharmaceutical sector, including the sudden departure of Susan Vogt from Millipore.
Deal sees PSMA mAb development for cancer
Biopharmaceutical company, Cytogen, and contract services provider Dowpharma have announced a collaboration to create a targeted oncology product designed to treat prostate and other cancers. The new treatment also demonstrates the progression...